Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same
申请人:Ryu Seong Eon
公开号:US20090042872A1
公开(公告)日:2009-02-12
Disclosed herein are rhodanine derivatives, a method for the preparation thereof, and a pharmaceutical composition containing the same. The rhodanine derivatives have inhibitory activity against protein phosphatases (PPase) such as PTP1B, Prl-3, LAR, CD45, Cdc25A, Cdc25B, Cdc25C, Yop, PP1 and VHR, and can be applied for the prevention and treatment of PPase-caused diseases, including autoimmune diseases, diabetes, impaired glucose intolerance, insulin resistance, obesity, cancers, etc. when the inhibitory activity thereof is modulated.
本文披露了罗丹宁衍生物、其制备方法以及含有相同物质的药物组合物。这些罗丹宁衍生物具有对蛋白磷酸酶(PPase)如PTP1B、Prl-3、LAR、CD45、Cdc25A、Cdc25B、Cdc25C、Yop、PP1和VHR的抑制活性,并可用于预防和治疗PPase引起的疾病,包括自身免疫疾病、糖尿病、糖耐量受损、胰岛素抵抗、肥胖、癌症等,当其抑制活性被调节时。